Systematic review / meta-analysis / 2011
Human evidence is currently insufficient to recommend resveratrol supplements beyond dietary intake levels.
A systematic review assessed published research to formulate recommendations regarding resveratrol intake for human health. The authors determined that human evidence was insufficient to support resveratrol administration beyond amounts typically supplied by dietary sources. Although experimental animal studies suggested potential benefits for diabetes, heart disease, and various cancers, clinical trials in humans were deemed necessary before recommending therapeutic dosing.
- Study type
- Systematic review
- Who was studied
- Human and animal studies
- What was measured
- Prevention or treatment of human diseases, side effects, and dosing
THE PAPER
What is new for an old molecule? Systematic review and recommendations on the use of resveratrol.
Vang O, Ahmad N, Baile CA, Baur JA, Brown K, Csiszar A, Das DK, Delmas D, Gottfried C, Lin HY, Ma QY, Mukhopadhyay P, Nalini N, Pezzuto JM, Richard T, Shukla Y, Surh YJ, Szekeres T, Szkudelski T, Walle T, Wu JM. PLoS One, 2011.
This note is written from the study's published abstract. It summarizes what the authors reported; it is not medical advice and does not replace reading the full paper.